recent
creat
cystic
fibrosi
ferret
model
acquir
neonat
lung
infect
develop
lung
gene
therapi
model
evalu
recombin
adenoassoci
viru
raav
mediat
gene
transfer
neonat
ferret
lung
unlik
vitro
ferret
airway
epitheli
fae
cell
vivo
infect
ferret
lung
requir
proteasom
inhibitor
achiev
effici
airway
transduct
hypothes
differ
transduct
two
system
vivo
secret
factor
alter
transduct
biolog
inde
treatment
ferret
airway
secretori
fluid
asf
strongli
inhibit
transduct
primari
fae
hela
cell
properti
asf
inhibitori
factor
includ
strong
affin
capsid
heatstabl
neg
charg
sensit
endoproteinas
gluc
asftreat
dramat
inhibit
apic
transduct
fae
ali
cultur
reduc
viral
entri
suggest
postentri
process
viru
influenc
inhibitor
factor
proteasom
inhibitor
rescu
transduct
presenc
asf
without
effect
viru
intern
proteasom
inhibitor
enhanc
transduct
absenc
asf
find
demonstr
factor
lung
secret
influenc
intracellular
process
proteasomedepend
fashion
c
ystic
fibrosi
cf
common
lifethreaten
autosom
recess
disord
caucasian
caus
defect
cystic
fibrosi
transmembran
conduct
regul
cftr
epitheli
dysfunct
multipl
organ
includ
lung
gastrointestin
tract
pancrea
liver
gallbladd
welsh
et
al
row
et
al
primari
target
gene
therapi
cf
lung
given
chronic
bacteri
infect
airway
lifethreaten
aspect
diseas
driskel
engelhardt
griesenbach
et
al
preclin
studi
test
efficaci
gene
therapi
cf
lung
hinder
fact
cf
mice
acquir
spontan
lung
diseas
grubb
boucher
wilk
et
al
like
altern
ca
activ
chlorid
channel
compens
lack
cftr
airway
grubb
boucher
interestingli
altern
chlorid
channel
mous
airway
epithelium
respons
camp
induct
make
difficult
function
evalu
cftr
complement
electrophysiolog
cf
mous
airway
epithelium
use
viral
vector
howev
recent
creation
new
cf
ferret
model
spontan
acquir
rapid
lung
infect
sun
et
al
provid
new
opportun
develop
test
gene
therapi
cf
lung
diseas
current
studi
sought
evalu
recombin
adenoassoci
viral
raav
vector
gene
therapi
neonat
ferret
lung
first
step
develop
model
raav
vector
extens
studi
field
gene
therapi
evalu
cf
clinic
trial
flott
carter
griesenbach
alton
although
phase
ii
trial
cf
lung
diseas
demonstr
promis
safeti
profil
cftr
express
trial
suffici
low
preclud
detect
transgenederiv
cftr
mrna
aitken
et
al
wagner
et
al
moss
et
al
vitro
studi
use
polar
human
airway
epithelia
hae
cultur
airliquid
interfac
ali
led
find
postentri
barrier
primarili
respons
low
effici
transduct
apic
surfac
duan
et
al
effici
intern
apic
basolater
membran
hae
entri
basolater
membran
effect
express
transgen
compar
apic
entri
duan
et
al
duan
et
al
apic
block
raav
transduct
appear
link
proteasom
function
ubiquitin
capsid
sinc
transient
inhibit
proteasom
time
infect
dramat
enhanc
capsid
ubiquitin
transduct
improv
nuclear
transloc
viru
duan
et
al
yan
et
al
variou
raav
serotyp
differ
suscept
proteasomedepend
block
apic
transduct
hae
least
sensit
sensit
yan
et
al
hae
ali
cultur
model
use
sort
raav
serotyp
highest
tropism
apic
surfac
yan
et
al
model
complet
reproduc
vivo
extracellular
environ
airway
contain
mucin
secret
compon
innat
immun
knowl
boucher
although
certain
raav
serotyp
demonstr
effect
vivo
airway
gene
transfer
mous
halbert
et
al
auricchio
et
al
bell
et
al
li
et
al
util
cf
mous
test
cftr
gene
transfer
limit
fail
develop
spontan
lung
infect
seen
cf
patient
guilbault
et
al
fisher
et
al
keiser
engelhardt
thu
need
evalu
raav
vector
less
studi
speci
like
ferret
eventu
appli
context
cftr
gene
therapi
cf
lung
diseas
previous
compar
transduct
effici
differ
raav
serotyp
polar
ferret
airway
epitheli
fae
cultur
grown
ali
discov
effect
express
transgen
apic
infect
compar
liu
et
al
therefor
current
studi
sought
evalu
effici
transduc
neonat
ferret
airway
vivo
found
effici
transduc
trachea
intralobar
airway
newborn
ferret
proteasom
inhibitor
appli
vector
inoculum
interestingli
adult
ferret
lung
consider
resist
infect
even
presenc
proteasom
inhibitor
find
stark
contrast
high
level
transduct
seen
vitro
infect
primari
fae
grown
ali
seek
better
understand
vivo
vitro
fae
resist
transduct
evalu
whether
airway
secretori
fluid
asf
ferret
contain
inhibitori
factor
alter
biolog
transduct
use
vitro
reconstitut
experi
demonstr
ferret
tracheal
wholelung
asf
contain
factor
alter
uptak
postentri
intracellular
process
proteasomedepend
fashion
apic
infect
airway
epithelia
studi
demonstr
first
time
extracellular
factor
influenc
intracellular
process
raav
shed
new
insight
potenti
innat
immun
barrier
limit
vivo
gene
deliveri
lung
character
extracellular
inhibitor
factor
may
lead
improv
raav
vector
engin
capsidinteract
domain
raav
vector
stock
gener
tripleplasmid
cotransfect
use
adenovirusfre
system
purifi
ident
procedur
involv
iodixanol
ultracentrifug
follow
hplc
previous
describ
construct
tripleplasmid
cotransfect
previous
describ
includ
adenoviru
helper
plasmid
aav
tran
helper
plasmid
either
raav
provir
plasmid
design
gener
packag
provir
plasmid
harbor
cmvpromoterdriven
firefli
luciferas
express
cassett
capsid
respect
vector
contain
rsvltrdriven
alkalin
phosphatas
express
cassett
contain
cmv
enhanc
chicken
actin
promot
cba
driven
renilla
luciferas
express
cassett
gener
provir
plasmid
pcwrapsp
yang
et
al
flott
et
al
respect
viral
titer
purifi
stock
calcul
dnaseresist
particl
drp
use
slot
blot
assay
p
label
probe
previous
describ
anim
experiment
perform
accord
protocol
approv
institut
anim
care
use
committe
univers
iowa
vivo
infect
ferret
lung
perform
intratrach
instil
administr
volum
viru
load
vari
depend
age
ferret
indic
figur
legend
proteasom
inhibitor
doxorubicin
dox
includ
vector
inoculum
final
concentr
lm
unless
otherwis
state
mock
infect
perform
intratrach
instil
phosphat
buffer
salin
pb
lack
viru
ferret
kit
anesthet
inhal
mixtur
isofluoran
oxygen
instal
inoculum
perform
min
vector
titer
volum
age
group
give
figur
legend
anim
euthan
desir
time
point
postinfect
overdos
sodium
pentobarbit
inject
ip
renilla
luciferas
express
assay
ferret
trachealung
cassett
immedi
frozen
liquid
nitrogen
pulver
use
cryogen
tissu
pulver
ml
passiv
lysi
buffer
promega
madison
wi
ad
pulver
tissu
extract
protein
freezethaw
cycl
tissu
extract
centrifug
rpm
min
clarifi
tissu
extract
use
renilla
luciferas
assay
renilla
luciferas
assay
kit
promega
detect
alkalin
phosphatas
express
situ
trachealung
cassett
wash
inflat
ml
pb
follow
instil
ml
fixat
solut
glutaraldehyd
pb
dissect
chest
caviti
trachea
lung
submerg
ml
fixat
solut
hr
wash
three
time
pb
cours
hr
last
pb
wash
tissu
fresh
pb
heat
water
bath
hr
inactiv
endogen
alkalin
phosphatas
activ
alkalin
phosphatas
stain
perform
dilut
nbtbcip
stock
solut
roch
indianapoli
trishcl
nacl
ph
buffer
contain
dilut
levamisol
vector
laboratori
burlingam
ca
stain
hr
tissu
rins
three
time
pb
cours
hr
postfix
buffer
formalin
proteasom
inhibitor
dox
sigma
st
loui
mo
llnl
nacetyllleucinelleucinelnorleucin
boston
biochem
cambridg
dynabead
antibodi
coupl
kit
invitrogen
carlsbad
ca
anion
poro
pi
cation
poro
hs
exchang
resin
appli
biosystem
foster
citi
ca
protenas
k
roch
sequencinggrad
endoproteinas
trypsin
argc
aspn
promega
nand
odeglycosidas
mix
pngase
f
endoanacetylgalactosaminidas
neuraminidas
galactosidas
nacetylglucosaminidas
new
england
biolab
ipswich
heparinas
chondroitinas
hyaluronidas
sigma
method
digest
variou
enzym
perform
condit
provid
manufactur
asf
ferret
differ
age
collect
euthanasia
lung
lavag
trachea
lung
cassett
dissect
chest
caviti
proxim
end
trachea
held
close
hemostat
adult
ferret
ml
steril
pb
inject
cannul
trachea
lung
lavag
procedur
repeat
lavag
pool
briefli
spun
rpm
min
supernat
filter
lm
filter
adjust
od
steril
pb
typic
ml
pbsdilut
asf
od
could
collect
one
adult
ferret
adult
tracheal
wash
harvest
pb
gave
similar
result
whole
lung
lavag
data
present
articl
use
asf
harvest
lung
lavag
hela
cell
cultur
monolay
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
penicillinstreptomycin
maintain
incub
co
fae
cultur
grown
ali
gener
previous
describ
liu
et
al
b
briefli
primari
epitheli
cell
obtain
adult
ferret
trachea
seed
onto
mm
millicel
cell
cultur
insert
millipor
billerica
differenti
ultros
g
usg
pall
corpor
port
washington
ny
medium
ali
week
use
infect
aav
vector
premix
pb
asf
room
temperatur
hr
aav
infect
hela
cell
perform
directli
ad
virus
multipl
infect
drpcell
drp
cell
cultur
plate
confluenc
virus
typic
left
cultur
medium
hr
infect
period
unless
otherwis
state
infect
polar
fae
ali
cultur
perform
apic
applic
drp
dilut
pb
premix
asf
final
volum
upper
chamber
millicel
insert
virus
expos
epithelia
hr
remov
time
millicel
insert
briefli
wash
small
amount
usg
medium
fed
fresh
usg
medium
bottom
chamber
approxim
cell
millicel
insert
thu
multipl
infect
drpcell
time
point
hr
postinfect
hela
cell
hr
postinfect
fae
ali
cultur
cell
lyse
luciferas
cell
lysi
buffer
luciferas
enzym
activ
cell
lysat
determin
use
luciferas
assay
system
promega
luminomet
equip
automat
injector
turner
biosystem
sunnyval
ca
time
point
hr
postinfect
hela
cell
hr
postinfect
fae
ali
cultur
viru
remov
extens
wash
pb
cell
detach
cultur
support
trypsin
digest
cell
pellet
wash
twice
pb
lyse
digest
buffer
contain
mm
kcl
mm
mgcl
mm
tri
ph
lgml
proteinas
k
digest
min
heat
inactiv
min
digest
mixtur
use
taqman
polymeras
chain
reaction
pcr
taqman
realtim
pcr
use
quantifi
physic
titer
viral
stock
copi
viral
genom
cell
lysat
aavinfect
cell
previous
describ
ding
et
al
yan
et
al
pcr
primer
use
forward
revers
amplifi
bp
fragment
genom
taqman
probe
synthes
idt
coralvil
ia
probe
tag
fluorescein
fam
report
dark
hole
quencher
quencher
pcr
perform
analyz
use
biorad
iq
realtim
pcr
detect
system
softwar
ding
et
al
yan
et
al
dpr
dilut
ml
pb
asf
incub
room
temperatur
hr
incub
viru
suspens
load
top
twolay
ml
sucrosepb
solut
aav
particl
pellet
yan
et
al
sucros
cushion
ultracentrifug
rpm
hr
ti
rotor
viru
pellet
resuspend
pb
use
transduct
assay
hela
cell
taqman
pcr
viral
genom
quantif
portion
origin
sampl
load
onto
sucros
also
retain
transduct
pcr
previou
compar
studi
transduct
polar
fae
ali
cultur
demonstr
afford
greater
transgen
express
vector
apic
infect
liu
et
al
studi
also
demonstr
coadministr
proteasom
inhibitor
time
infect
could
enhanc
apic
transduct
fae
ali
cultur
serotyp
similar
manner
observ
hae
ali
cultur
howev
transduct
hae
fae
ali
cultur
less
respons
proteasom
inhibitor
induct
suggest
less
suscept
ubiquitinproteasomedepend
barrier
apic
infect
initi
studi
evalu
vivo
intratrach
infect
neonat
ferret
lung
without
coadministr
proteasom
inhibitor
fail
detect
transgen
express
fig
suggest
biolog
transduct
vivo
differ
polar
fae
ali
cultur
end
sought
determin
whether
coadministr
proteasom
inhibitor
dox
could
enhanc
vivo
transduct
perform
dose
respons
dox
administr
cbadriven
rellina
luciferas
report
flott
et
al
surpris
transduct
neonat
ferret
lung
intratrach
deliveri
remark
augment
inclus
dox
vector
inoculum
dose
lm
dox
transgen
express
lung
lysat
induc
respect
fig
confirm
find
altern
promoterdriven
report
perform
similar
experi
use
rsv
ltrpromoterdriven
alkalin
phosphatas
vector
yang
et
al
use
histochem
stain
determin
cellular
target
transduct
similar
find
transduct
significantli
enhanc
addit
dox
vector
inoculum
transgen
express
observ
absenc
dox
infect
kit
transgen
express
observ
tracheobronchi
epithelium
bronchiol
scatter
alveolar
cell
fig
e
infect
perform
adult
ferret
presenc
dox
transgen
express
airway
significantli
lower
anim
fig
undetect
adult
anim
data
shown
fig
proteasom
inhibitor
dramat
induc
transduct
ferret
lung
fourteendayold
ferret
infect
drp
inoculum
contain
indic
concentr
dox
intratrach
instil
graph
show
mean
sem
luciferas
activ
rlumg
protein
measur
day
postinfect
n
anim
condit
bd
fivedayold
ferret
infect
drp
presenc
absenc
lm
dox
lg
inoculum
e
twelvedayold
ferret
infect
drp
presenc
lm
dox
lg
inoculum
embed
lung
sampl
inflat
f
eighteendayold
ferret
infect
drp
presenc
lm
dox
lg
inoculum
dark
purpl
stain
demonstr
express
alkalin
phosphatas
report
day
postinfect
imag
cf
acquir
magnif
dox
doxorubicin
drp
dnaseresist
particl
raav
recombin
adenoassoci
viru
sem
standard
error
mean
color
imag
avail
onlin
wwwliebertpubcomhum
adult
ferret
tracheal
asf
contain
inhibitori
factor
select
block
transduct
rel
effici
transduc
polar
fae
ali
cultur
vitro
absenc
proteasom
inhibitor
contrast
vivo
transduct
ferret
airway
requir
high
concentr
dox
achiev
effici
transgen
express
furthermor
adult
ferret
lung
refractori
transduct
even
presenc
dox
thu
appear
ferret
lung
develop
host
defens
mechan
age
compromis
infect
vivo
hypothes
specif
factor
within
asf
might
act
extracellular
barrier
block
vivo
access
airway
epithelium
test
hypothesi
investig
whether
asf
harvest
adult
ferret
tracheal
wash
bronchoalveolar
lavag
contain
substanc
capabl
inhibit
infect
evalu
specif
toward
serotyp
perform
compar
experi
incub
ferret
asf
pb
room
temperatur
hr
appli
hela
cell
result
experi
demonstr
ferret
asf
inhibit
transduct
transduct
level
transgen
express
hela
cell
infect
asfexpos
pbstreat
control
viru
fig
inhibitori
effect
specif
sinc
transgen
express
infect
asfor
pbstreat
unchang
fig
inhibitori
effect
asf
transduct
hela
cell
mediat
fig
inhibit
transduct
ferret
asf
drp
incub
ferret
asf
lgll
pb
room
temperatur
hr
appli
hela
cell
cultur
plate
cellwel
moi
drpcell
luciferas
assay
perform
hr
postinfect
data
repres
mean
sem
rel
luciferas
activ
per
well
n
independ
well
b
hela
cell
plate
overlaid
pb
black
column
asf
gray
column
incub
hr
remov
pb
asf
cell
fed
complet
cultur
medium
infect
moi
drpcell
premix
ferret
asf
lgll
pb
room
temperatur
hr
infect
luciferas
assay
perform
hr
postinfect
data
repres
mean
sem
rel
luciferas
activ
per
well
n
independ
well
c
prechil
hela
cell
incub
drp
premix
pb
asf
hr
viru
bound
cell
surfac
hr
intern
cell
addit
hr
incub
access
taqman
pcr
viral
genom
copi
data
repres
mean
sem
n
infect
drp
incub
differ
amount
ferret
asf
room
temperatur
hr
appli
hela
cell
cultur
plate
cellwel
luciferas
assay
perform
hr
postinfect
data
repres
mean
sem
rel
luciferas
activ
per
well
n
independ
well
e
drp
incub
ferret
asf
differ
age
room
temperatur
hr
appli
hela
cell
cultur
plate
cellwel
luciferas
assay
perform
hr
postinfect
data
repres
mean
sem
rel
luciferas
activ
per
well
n
independ
well
asf
airway
secretori
fluid
pb
phosphat
buffer
salin
moi
multipl
infect
yan
et
al
virionasf
interact
sinc
preexposur
asf
cell
absenc
viru
follow
viral
infect
absenc
asf
alter
transduct
fig
furthermor
premix
asf
infect
block
bind
viru
hela
cell
thu
also
intern
shift
fig
extent
asfmedi
inhibit
transduct
depend
concentr
asf
viru
fig
transduct
activ
drp
inhibit
incub
lg
asf
higher
viral
inoculum
inhibit
requir
lg
asf
respect
fig
nonlinear
relationship
asf
concentr
viral
inoculum
titer
suggest
asf
inhibitori
factor
might
cooper
act
inhibit
virion
bind
cell
surfac
given
differ
transduct
observ
vivo
infect
ferret
variou
age
fig
hypothes
asf
inhibitori
factor
increas
abund
becam
activ
ferret
matur
test
hypothesi
asf
collect
ferret
variou
age
rang
newborn
adult
asf
use
titrat
dosedepend
inhibit
transduct
hela
cell
result
analysi
fig
demonstr
abil
asf
inhibit
transduct
inde
increas
age
differ
specif
activ
asf
seen
ferretsboth
age
retain
inhibitori
activ
inhibit
transduct
observ
lg
asf
contrast
asf
adult
ferret
inhibit
transduct
significantli
give
rise
inhibit
transduct
lg
asf
respect
find
correl
decreas
effici
transduc
ferret
airway
anim
age
fig
f
suggest
either
inhibitori
activ
abund
inhibitori
factor
increas
asf
age
investig
whether
asfmedi
inhibit
transduct
result
reduc
viral
entri
end
incub
ferret
asf
pb
control
room
temperatur
hr
appli
hela
cell
cell
expos
vector
inoculum
hr
absenc
presenc
lm
dox
refe
fresh
medium
inoculum
remov
hr
postinfect
cell
assess
intern
viral
genom
luciferas
report
express
fig
b
result
analys
demonstr
significantli
reduc
intern
asf
preexpos
also
reveal
direct
correl
intern
viral
genom
transgen
express
asf
inhibit
led
decreas
transgen
express
regardless
dox
treatment
similar
reduct
vector
uptak
inhibit
proteasom
shown
enhanc
raav
transduct
postentri
virion
process
traffick
minim
effect
viral
uptak
hela
cell
yan
et
al
thu
result
fig
b
consist
observ
given
transgen
express
per
viral
genom
similarli
enhanc
presenc
dox
regardless
asf
inhibit
fig
find
suggest
asf
alter
proteasomedepend
process
intern
virion
hela
cell
thu
primari
mechan
asf
inhibit
transduct
hela
cell
reduc
viru
bind
intern
evalu
whether
asf
inhibitori
factor
enzym
might
modifi
viru
capsid
prevent
bindingendocytosi
first
investig
whether
inhibit
could
revers
heat
inactiv
min
asf
mix
infect
hela
cell
result
demonstr
inhibitor
asf
resist
heat
inactiv
thu
like
enzym
fig
next
perform
studi
determin
asf
inhibitori
factor
protein
defin
biochem
properti
summar
fig
result
experi
suggest
inhibitori
factor
heatstabl
protein
net
neg
charg
predigest
asf
proteinas
k
follow
heat
inactiv
proteinas
k
preadsorpt
asf
use
anion
exchang
resin
significantli
deplet
asf
inhibitori
activ
hela
cell
transduct
assay
inhibitori
factor
also
sensit
endoproteinas
gluc
digest
resist
endoproteinas
trypsin
argc
aspn
inhibitori
factor
also
resist
digest
nand
odeglycosidas
heparinas
chondroitinas
hyaluronidas
suggest
glycan
modif
respons
inhibitori
effect
transduct
evalu
specif
bind
inhibitor
factor
capsid
bind
characterist
asf
factor
examin
use
dynabead
coval
coupl
asf
preclear
fail
block
transduct
hela
cell
comparison
signific
inhibit
observ
mockclear
asf
ie
use
dynabead
alon
fig
notabl
inhibitori
factor
bound
extrem
tightli
dynabead
could
elut
high
salt
nacl
data
shown
furthermor
asfbound
viru
retain
reduc
transduct
activ
pellet
fig
biochem
properti
inhibitori
factor
ferret
asf
ac
infect
perform
hela
cell
cultur
plate
cellwel
drp
incub
asf
pb
hr
infect
indic
asf
pretreat
incub
viru
luciferas
activ
cell
lysat
determin
hr
postinfect
ferret
asf
preheat
min
infect
assay
retain
inhibitori
activ
transduct
data
repres
mean
sem
valu
n
independ
infect
b
ferret
asf
treat
agent
shown
yaxi
enzymat
treatment
asf
heat
min
inactiv
enzym
mix
nodeglycosidas
mixtur
contain
five
enzym
pngase
f
endoanacetylgalactosaminidas
neuraminidas
galactosidas
nacetylglucosaminidas
anion
cation
exchang
resin
use
preclear
asf
mix
asf
dri
volum
resin
slurri
preequilibr
pb
result
indic
mean
sem
inhibitori
activ
respect
transduct
assay
n
independ
infect
remain
asf
compar
untreat
control
asf
c
coval
conjug
dynabead
use
dynabead
antibodi
coupl
kit
invitrogen
use
preclear
asf
incub
infect
hela
cell
mock
control
bead
run
coupl
reaction
absenc
data
repres
mean
sem
valu
n
independ
infect
e
dpr
mix
ml
pb
asf
hr
incub
room
temperatur
viru
solut
load
onto
top
two
layer
ml
sucrosepb
solut
wv
spun
rpm
hr
ti
rotor
spin
viru
pellet
resuspend
pb
use
quantif
viral
genom
taqman
pcr
e
quantif
viral
transduct
recoveri
viru
pellet
pb
condit
asf
condit
approxim
drp
spin
mix
pb
asf
spin
sucros
pellet
use
infect
hela
cell
luciferas
report
express
assay
conduct
hr
postinfect
data
repres
mean
sem
n
independ
experi
yan
et
al
sucros
step
gradient
fig
e
emphas
strong
bind
interact
inhibitori
factor
capsid
result
analysi
demonstr
dnacontain
particl
recov
sucros
pellet
either
pb
asf
incub
fig
asfbound
viru
demonstr
similar
inhibit
transduct
hela
cell
sucros
purif
fig
next
sought
determin
manner
ferret
asf
might
alter
transduct
polar
fae
ali
cultur
basi
find
hela
cell
hypothes
factor
might
inhibit
viral
uptak
inde
preincub
asf
significantli
reduc
viral
uptak
apic
surfac
fig
similar
hela
cell
studi
viral
uptak
presenc
absenc
asf
unaffect
treatment
proteasom
inhibitor
time
infect
fig
surprisingli
howev
asf
significantli
inhibit
transduct
ali
cultur
fig
viral
uptak
unlik
find
hela
cell
furthermor
proteasom
inhibit
time
infect
significantli
rescu
transduct
presenc
asf
fig
proteasom
inhibit
increas
transduct
absenc
asf
find
suggest
although
inhibitori
factor
asf
reduc
endocytosi
fae
also
redirect
get
intern
proteasomesensit
pathway
transduct
light
chang
viral
uptak
presenc
asf
easili
appreci
evalu
function
intern
vector
genom
express
transgen
fig
proteasom
inhibitor
increas
function
vector
genom
rluvg
presenc
asf
ie
increas
presenc
asf
vs
increas
absenc
asf
contrast
find
hela
cell
proteasom
inhibit
similarli
increas
function
genom
presenc
absenc
asf
respect
find
provid
insight
vivo
ferret
airway
highli
resist
transduct
absenc
proteasom
inhibitor
studi
demonstr
may
suitabl
viral
vector
test
gene
therapi
lung
neonat
cf
ferret
interestingli
airway
adult
ferret
extrem
resist
transduct
appear
caus
least
part
increas
abund
secret
inhibitori
factor
adult
ferret
airway
ident
secret
inhibitori
factor
remain
unknown
howev
resist
airway
infect
appear
develop
day
birth
time
point
submucos
gland
near
matur
state
ferret
leigh
et
al
liu
et
al
thu
inhibitor
factor
may
origin
airway
gland
one
group
previous
note
inhibitori
factor
specif
cf
bronchioalveolar
lavag
noncf
reduc
infect
cell
line
virellalowel
et
al
author
conclud
like
inhibitor
factor
human
neutrophil
peptid
studi
shed
new
insight
inhibitori
factor
found
lung
impact
raav
transduct
alter
intracellular
process
virion
specif
asf
inhibitori
factor
toward
block
transduct
intrigu
fig
ferret
asf
influenc
transduct
ferret
airway
epithelia
alter
uptak
proteasomedepend
intracellular
process
ac
drp
mix
ferret
asf
pb
incub
hr
room
temperatur
inoculum
apic
appli
fae
ali
cultur
moi
drpcell
hr
proteasom
inhibitor
pi
appli
ad
medium
basolater
chamber
final
concentr
lm
dox
nm
nacetyllleucinelleucinelnorleucin
llnl
entir
infect
period
hr
postinfect
apic
inoculum
remov
wash
cultur
either
lyse
analys
intern
viral
genom
taqman
pcr
b
fed
fresh
medium
basolater
chamber
cultur
till
day
postinfect
luciferas
express
assay
c
vector
effici
differ
infect
condit
calcul
ratio
luciferas
express
number
viral
genom
sampl
hr
postinfect
data
repres
mean
sem
valu
n
independ
infect
suggest
interact
capsid
specif
abil
inhibitori
factor
bind
tightli
capsid
emphas
fact
asf
prebound
retain
inhibitori
activ
transduct
sucros
gradient
purif
fig
e
find
nacl
fail
elut
inhibitori
factor
viru
given
sensit
inhibitori
factor
proteinas
k
endoproteinas
gluc
conclud
protein
howev
protein
highli
resist
heat
denatur
endoproteinas
given
neg
charg
asf
inhibitori
factor
conclud
defensin
unlik
candid
sinc
highli
posit
charg
although
asf
inhibitori
factor
reduc
uptak
hela
cell
primari
fae
interest
differ
like
account
abil
proteasom
inhibitor
rescu
transduct
presenc
asf
airway
epithelium
vitro
vivo
hela
cell
asf
inhibit
endocytosi
transduct
similar
extent
thu
hela
cell
function
intern
vector
genom
remain
presenc
absenc
asf
inhibit
ie
index
ratio
transgen
expressionintern
viral
genom
fig
although
proteasom
inhibitor
augment
transduct
hela
cell
function
endocytos
viral
genom
remain
presenc
absenc
asf
dox
present
thu
hela
cell
pathway
asf
inhibit
appear
primarili
level
block
viral
bindingendocytosi
alter
intracellular
proteasomedepend
process
contrast
studi
hela
cell
reconstitut
experi
fae
show
asf
strongli
inhibit
function
genom
decreas
viral
uptak
transduct
fig
find
suggest
intracellular
process
intern
virion
also
inhibit
asf
inhibitori
factor
abil
proteasom
inhibitor
rescu
asfinhibit
transduct
support
hypothesi
even
strike
fact
asftreat
presenc
proteasom
inhibitor
gave
rise
greater
function
intern
viral
genom
untreat
presenc
proteasom
inhibitor
fig
find
suggest
asf
inhibitor
factor
rout
intern
viru
highli
proteasomesensit
compart
within
airway
epithelia
thu
render
transduct
greater
modul
proteasom
inhibitor
given
larg
bodi
work
abil
proteasom
inhibitor
improv
traffick
sever
aav
serotyp
nucleu
like
mechan
improv
transduct
presenc
asf
inhibitori
factor
howev
mechan
asf
enhanc
viru
traffick
proteasomesensit
compart
remain
unclear
could
occur
chang
primari
receptorcoreceptor
pair
bind
asf
factor
capsid
site
normal
bind
abund
primari
receptorcoreceptor
cell
surfac
airway
epithelia
altern
asf
factor
may
enter
virion
normal
receptorcoreceptor
alter
postendocyt
virion
process
intrigu
find
neonat
ferret
less
week
age
highli
transduc
presenc
proteasom
inhibitor
ferret
older
day
age
lose
sensit
hypothes
lower
abund
asf
inhibitori
factor
rout
viru
intracellular
compart
highli
modul
proteasom
inhibitor
find
consist
vitro
fae
data
howev
given
asf
inhibitori
factor
also
block
bind
uptak
fae
hypothes
factor
reach
critic
concentr
ferret
lung
mechan
inhibit
predomin
littl
intern
viru
rerout
nucleu
proteasom
inhibitor
treatment
innat
immun
system
provid
immedi
protect
viral
infect
play
import
role
stimul
adapt
immun
respons
innat
immun
mechan
envelop
nonenvelop
virus
attack
nearli
stage
infecti
process
includ
bind
endocytosi
endosom
escap
viru
process
cytoplasm
gaiha
et
al
see
wark
ding
et
al
brennan
bowi
faur
rabourdincomb
secret
defensin
cytosol
membranebound
pattern
recognit
receptor
tolllik
receptor
two
exampl
ding
et
al
brennan
bowi
faur
rabourdincomb
airway
epithelium
multipl
modal
innat
immun
includ
passiv
ie
mechan
clearanc
resid
activ
biomolecul
airway
secret
ie
defensin
surfact
protein
reactiv
system
ie
pattern
recognit
receptor
diamond
et
al
see
wark
virus
evolv
differ
entri
intracellular
traffick
mechan
evad
innat
host
surveil
exampl
lung
surfact
protein
commonli
inhibit
infect
mani
respiratori
virus
matalon
wright
bind
surfact
protein
cytomegaloviru
enhanc
viru
entri
lung
cell
weyer
et
al
cellular
function
ubiquitinproteasom
system
up
also
affect
viru
infect
stage
life
cycl
yu
lai
gao
luo
howev
virus
also
adapt
counteract
immun
defens
inhibit
redirect
host
up
viswanathan
et
al
exampl
certain
wildtyp
parvovirus
requir
activ
up
transloc
nucleu
ro
kempf
case
mani
enhanc
ubiquitin
capsid
presenc
proteasom
inhibitor
correl
enhanc
nuclear
transloc
duan
et
al
yan
et
al
although
mechan
proteasom
inhibitor
counteract
innat
immun
factor
found
ferret
asf
remain
unclear
find
suggest
factor
found
biolog
fluid
passiv
bind
aav
dramat
influenc
entri
postentri
process
virion
summari
studi
describ
exist
protein
inhibitor
airway
fluid
compromis
transduct
ferret
airway
vivo
inhibit
uptak
viru
postentri
process
interestingli
bind
asf
rerout
intern
virion
nonproduct
pathway
rescu
applic
proteasom
inhibitor
better
understand
inhibitori
factor
influenc
transduct
biolog
proteasom
inhibitor
rescu
viru
import
improv
design
raavbas
gene
therapi
cf
yan
et
al
whether
similar
innat
immun
factor
exist
biolog
fluid
andor
act
serotyp
raav
remain
unclear
warrant
investig
given
proteasom
inhibitor
appear
enhanc
raav
transduct
sever
raav
serotyp
vivo
deliveri
sever
organ
includ
vasculatur
liver
joint
denbi
et
al
jen
et
al
finn
et
al
monahan
et
al
mechan
proteasom
inhibitor
enhanc
raav
transduct
vivo
organ
may
molecular
basi
complex
previous
thought
despit
find
ferret
asf
strongli
inhibit
vivo
transduct
ferret
airway
reason
transgen
express
achiev
younger
ferret
kit
infect
age
day
old
proteasom
inhibitor
administ
time
infect
thu
may
use
test
gene
therapi
neonat
cf
ferret
lung
